Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 05/19/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Mediterranean Dietary Treatment in Hyperlipidemic Children: Should It Be an Option?

Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data.

Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia.

Features of chinese patients with sitosterolemia.

Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia.

Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players.

Detection of Familial Hypercholesterolemia through centralized analytical data. HF HUELVA DETECTA Program.

Past, Present, and Future of Familial Hypercholesterolemia Management.

A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia.

Longitudinal evaluation of endothelial markers in children and adolescents with familial hypercholesterolemia.

Familial Hypercholesterolemia: JACC Focus Seminar 4/4.

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors.

Showing 1-12 of 77

Last Updated : 05/19/2022